6505--Blood Products IDIQ SFVAHCS

The contract involves an Indefinite Delivery Indefinite Quantity (IDIQ) arrangement for blood, blood products, and necessary testing services at the Sioux Falls VA Healthcare System, issued by the Department of Veterans Affairs Network Contract Office 23. The solicitation, posted on November 12, 2025, with a response deadline of December 12, 2025, emphasizes a Lowest Price Technically Acceptable evaluation process, with an estimated total award value of up to $40 million. Offerors are required to submit comprehensive proposals electronically, including a signed SF 1449, completed price schedules, signed amendments, descriptive literature demonstrating their capability to meet the scope of work, and a completed supply line item template. The scope encompasses a range of blood products such as red blood cells, platelets, cryoprecipitate, and testing services, with specific quantities and periods of performance from October 1, 2030, to January 31, 2031. The solicitation references standard FAR and VAAR clauses governing contract terms, ordering procedures, and compliance requirements, with no unique or special contract clauses explicitly identified beyond those incorporated by reference. The evaluation is solely based on technical acceptability (pass/fail) and price, with the award going to the lowest priced offer that meets the technical standards. The contract stipulates that all deliveries and testing services will be performed at the VA Medical Center, with inspection and acceptance conducted by the government upon delivery, ensuring conformity to specified standards and regulations, including AABB and FDA guidelines. The contract emphasizes strict adherence to packaging, preservation, and labeling standards for blood products, requiring proper temperature control, accurate labeling with blood type and expiration data, and compliance with applicable standards. Payment will be processed electronically, and the contract administration will be overseen by designated VA contracting personnel, with the period of performance set within the specified dates. Overall, the contract aims to establish a reliable, compliant supply chain for blood products and testing services to support veteran healthcare needs within the defined performance window.